In the last trading session, 1.0 million shares of the Purple Biotech Ltd ADR (NASDAQ:PPBT) were traded, and its beta was 1.11. Most recently the company’s share price was $0.39, and it changed around $0.03 or 7.50% from the last close, which brings the market valuation of the company to $12.45M. PPBT currently trades at a discount to its 52-week high of $1.80, offering almost -361.54% off that amount. The share price’s 52-week low was $0.30, which indicates that the current value has risen by an impressive 23.08% since then. We note from Purple Biotech Ltd ADR’s average daily trading volume that its 10-day average is 0.27 million shares, with the 3-month average coming to 289.04K.
Purple Biotech Ltd ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended PPBT as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Purple Biotech Ltd ADR is expected to report earnings per share of -0.16 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Purple Biotech Ltd ADR (NASDAQ:PPBT) trade information
Instantly PPBT has showed a green trend with a performance of 7.50% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4700 on recent trading dayincreased the stock’s daily price by 17.02%. The company’s shares are currently down -50.38% year-to-date, but still down -14.10% over the last five days. On the other hand, Purple Biotech Ltd ADR (NASDAQ:PPBT) is 4.71% up in the 30-day period. We can see from the shorts that 0.42 million shares have been sold at a short interest cover period of 3.47 day(s).
Purple Biotech Ltd ADR (PPBT) estimates and forecasts
Purple Biotech Ltd ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -44.34 percent over the past six months and at a 68.00% annual growth rate that is well above the industry average of 17.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 36.00% in revenue this quarter, and will report an increase of 39.10% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 26.09%.
PPBT Dividends
Purple Biotech Ltd ADR’s next quarterly earnings report is expected to be released in October.
KINGSWOOD WEALTH ADVISORS, LLC, with 0.8021% or 0.21 million shares worth $84680.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
